Isolation of Candida auris in Clinical Specimens
- PMID: 35674941
- DOI: 10.1007/978-1-0716-2417-3_1
Isolation of Candida auris in Clinical Specimens
Abstract
Candida auris is a multidrug-resistant yeast causing healthcare-associated outbreaks of blood stream infections worldwide. Currently, C. auris isolation and identification is complicated by issues such as misidentification and long turnaround time associated with application of commonly used diagnostic tools. Based on phenotypic characteristics, differentiation of C. auris from related Candida haemulonii complex spp. is problematic. Candida auris can be misidentified using biochemical-based systems such as VITEK 2 YST, API 20C, BD Phoenix yeast identification system, and MicroScan. C. auris growth at 42 °C and in the presence of 10% NaCl helps in presumptive identification of this yeast from related Candida haemulonii complex spp. A new CHROMagar™ Candida Plus agar is an excellent alternative to current conventional mycological media for the screening of patients colonized/infected with Candida auris. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) can differentiate C. auris from other Candida species, but not all the reference databases included in MALDI-TOF devices allow for detection. Currently, accurate identification of C. auris can be performed using the updated FDA-approved libraries or "research use-only" libraries. Molecular techniques have greatly enhanced the diagnosis of C. auris. Sequencing of rDNA genetic loci, namely, internal transcribed spacer and D1/D2 region of large subunit (LSU), and PCR/qPCR assays has successfully been applied for identification of C. auris. Real-time PCR assays bear incomparable potential of being the most efficient tool for high-throughput screening of surveillance samples. If properly validated, they can deliver the diagnostic result within several hours, since the DNA can be isolated directly from the patient specimen without the need of obtaining a colony. In this chapter we detailed the isolation of Candida auris from various clinical specimens and its currently available identification methods and hitches.
Keywords: CHROMagar Candida; Candida auris; Misidentification; Molecular identification; Phenotypic identification.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.J Clin Microbiol. 2015 Jun;53(6):1823-30. doi: 10.1128/JCM.00367-15. Epub 2015 Mar 25. J Clin Microbiol. 2015. PMID: 25809970 Free PMC article.
-
Utility of CHROMagar™ Candida Plus for presumptive identification of Candida auris from surveillance samples.Mycopathologia. 2022 Dec;187(5-6):527-534. doi: 10.1007/s11046-022-00656-3. Epub 2022 Nov 10. Mycopathologia. 2022. PMID: 36355325 Free PMC article.
-
Improvement of a MALDI-TOF database for the reliable identification of Candidozyma auris (formally Candida auris) and related species.Microbiol Spectr. 2025 Jan 7;13(1):e0144424. doi: 10.1128/spectrum.01444-24. Epub 2024 Nov 19. Microbiol Spectr. 2025. PMID: 39560426 Free PMC article.
-
Tools for Detecting a "Superbug": Updates on Candida auris Testing.J Clin Microbiol. 2022 May 18;60(5):e0080821. doi: 10.1128/jcm.00808-21. Epub 2022 Jan 5. J Clin Microbiol. 2022. PMID: 34985980 Free PMC article. Review.
-
Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.Intern Med J. 2019 Oct;49(10):1229-1243. doi: 10.1111/imj.14612. Intern Med J. 2019. PMID: 31424595 Review.
Cited by
-
Mining the nanotube-forming Bacillus amyloliquefaciens MR14M3 genome for determining anti-Candida auris and anti-Candida albicans potential by pathogenicity and comparative genomics analysis.Comput Struct Biotechnol J. 2023 Sep 1;21:4261-4276. doi: 10.1016/j.csbj.2023.08.031. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 37701018 Free PMC article.
-
Genome-Guided Identification of Surfactin-Producing Bacillus halotolerans AQ11M9 with Anti-Candida auris Potential.Int J Mol Sci. 2024 Sep 27;25(19):10408. doi: 10.3390/ijms251910408. Int J Mol Sci. 2024. PMID: 39408762 Free PMC article.
References
-
- Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G (2020) Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog 16:e1008921. https://doi.org/10.1371/journal.ppat.1008921 - DOI - PubMed - PMC
-
- Adams E, Quinn M, Tsay S et al (2018) Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis 24:1816–1824. https://doi.org/10.3201/eid2410.180649 - DOI - PubMed - PMC
-
- Yadav A, Singh A, Wang Y et al (2021) Colonisation and transmission dynamics of Candida auris among chronic respiratory diseases patients hospitalised in a chest hospital, Delhi, India: a comparative analysis of whole genome sequencing and microsatellite typing. J Fungi (Basel) 7:81. https://doi.org/10.3390/jof7020081 - DOI
-
- Pacilli M, Kerins JL, Clegg WJ et al (2020) Regional emergence of Candida auris in Chicago and lessons learned from intensive follow-up at 1 ventilator-capable skilled nursing facility. Clin Infect Dis 71:e718–e725. https://doi.org/10.1093/cid/ciaa435 - DOI - PubMed
-
- Ambaraghassi G, Dufresne PJ, Dufresne SF et al (2019) Identification of Candida auris by use of the updated Vitek 2 yeast identification system, Version 8.01: a multilaboratory evaluation study. J Clin Microbiol 57:e00884–e00819. https://doi.org/10.1128/JCM.00884-19 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
